Moderna co-founder and board chairman Noubar Afeyan discusses the phase three success of the Moderna-Merck cancer vaccine trial and explains how the vaccine targets unique mutations to help prevent melanoma recurrence on ‘The Claman Countdown.’ #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #moderna #merck #cancer #vaccine #health #medicine #medical #melanoma #science #research #trial #biotech #technology #treatment #breakthrough #healthcare #innovation
Could a common medication help fight cancer? And what are American tourists saying after returning to Israel? In today's NEWSMAX Israel Update, Katrina Szish reports on new research from Israeli scientists who say the active ingredient in Viagra may help prevent cancer from spreading. The findings were based on mouse cancer models and decades of research, with clinical trials identified as a possible next step. Then, correspondent Jodie Cohen speaks with American visitors in Tel Aviv and Hostages Square, where tourists share their reactions to returning to Israel and reflect on the country's resilience and recovery.
Brain implants like those being developed by Elon Musk's Neuralink are becoming the latest friction point in the intensifying U.S.-China rivalry in the life sciences. Why it matters: The devices are bringing new hope to patients with strokes, Parkinson's disease and other neurological conditions. And tech billionaires have fueled advances by pouring billions into biotech startups focused on linking the brain with computers. - But a new national security analysis says U.S. development efforts are being overtaken by Beijing's full-court press around manufacturing, data and commercialization. - The consequences could extend beyond health care, affecting U.S. military capabilities and the ability to train the next generation of AI…
Personalized vaccines could be around the corner thanks to decades of work by doctors like Michelle Wu. Her story and details on the new breakthrough on tonight's 11th Hour with Ali Velshi.
Last year, Health and Human Services Secretary RFK Jr. called mRNA vaccines for respiratory viruses unsafe for the public and the National Institutes of Health cut 22 programs totaling $500 million that targeted mRNA vaccine research for infectious diseases. Now, that same technology has succeeded in a clinical trial for treating skin cancer. CNN’s Meg Tirrell reports.
Interim results from the trial show that the vaccine-drug combination appeared to increase the time before cancer returned in the high-risk patients, the companies said.
The strain of the virus that's responsible for the current outbreak has no specific treatments or preventive measures. Three new clinical trials could provide possible breakthroughs.
A patient is being tested for Ebola at a hospital in Glasgow, Scotland in the United Kingdom.
A hospital in Glasgow, Scotland, is testing a patient for suspected Ebola, marking Britain’s first suspected case since an Ebola outbreak in Central Africa was announced in May. PULSE POINTS WHAT HAPPENED: A patient is being tested for Ebola at a hospital in Glasgow, Scotland. DETAIL: On Tuesday, it was announced that a patient was being tested for Ebola at Queen Elizabeth University Hospital in Glasgow. While Public Health Scotland (PHS), the country’s main public health agency, has stated that there are currently no confirmed cases of the virus in Scotland, if the patient tests positive, it will be the first case of Ebola in the United Kingdom since the outbreak in the Democratic Republic of Congo (DRC) was announced earlier this…Open
